Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Return on Sales: 2019-2025

Historic Return on Sales for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to 0.38%.

  • Catalyst Pharmaceuticals' Return on Sales rose 9.00% to 0.38% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.38%, marking a year-over-year increase of 9.00%. This contributed to the annual value of 0.33% for FY2024, which is 18.00% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Return on Sales stood at 0.38% for Q3 2025, which was up 0.72% from 0.37% recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Return on Sales peaked at 0.60% during Q1 2021, and registered a low of 0.13% during Q1 2024.
  • In the last 3 years, Catalyst Pharmaceuticals' Return on Sales had a median value of 0.33% in 2024 and averaged 0.28%.
  • Within the past 5 years, the most significant YoY rise in Catalyst Pharmaceuticals' Return on Sales was 24bps (2021), while the steepest drop was 35bps (2021).
  • Catalyst Pharmaceuticals' Return on Sales (Quarterly) stood at 0.28% in 2021, then rose by 11bps to 0.39% in 2022, then decreased by 24bps to 0.15% in 2023, then climbed by 18bps to 0.33% in 2024, then grew by 9bps to 0.38% in 2025.
  • Its Return on Sales was 0.38% in Q3 2025, compared to 0.37% in Q2 2025 and 0.37% in Q1 2025.